{"DataElement":{"publicId":"10811972","version":"1","preferredName":"Target Concomitant Agent Gamma Globulin Immunosuppressive Therapy Vaccination Indicator","preferredDefinition":"Indicator of whether medication is a targeted concomitant medication such as gamma globulin, immunosuppressive drug or vaccination.","longName":"GAMMAG_CMOCCUR","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"10811970","version":"1","preferredName":"Target Concomitant Agent Gamma Globulin Immunosuppressive Therapy Vaccination","preferredDefinition":"An object fixed as a goal or point of examination; something to point at; a destination._A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.:A type of globulin in plasma that in electrically charged solutions exhibits slowest colloidal mobility after that of the alpha and beta globulins. All immunoglobulins belong to this group of serum protein._deliberate suppression of immune system function for experimental or therapeutic purposes._Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis or treatment.","longName":"10811968v1.00:10811969v1.00","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"10811968","version":"1","preferredName":"Target Concomitant Agent","preferredDefinition":"An object fixed as a goal or point of examination; something to point at; a destination._A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","longName":"C25702:C70902","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4E3E2D2-0512-08F9-E053-731AD00AFB64","latestVersionIndicator":"Yes","beginDate":"2022-07-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-28","modifiedBy":"TSESU","dateModified":"2022-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"10811969","version":"1","preferredName":"Gamma Globulin Immunosuppressive Therapy Vaccination","preferredDefinition":"A type of globulin in plasma that in electrically charged solutions exhibits slowest colloidal mobility after that of the alpha and beta globulins. All immunoglobulins belong to this group of serum protein._deliberate suppression of immune system function for experimental or therapeutic purposes._Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis or treatment.","longName":"C16601:C15261:C15346","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gamma Globulin","conceptCode":"C16601","definition":"A type of globulin in plasma that in electrically charged solutions exhibits slowest colloidal mobility after that of the alpha and beta globulins. All immunoglobulins belong to this group of serum protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunosuppressive Therapy","conceptCode":"C15261","definition":"deliberate suppression of immune system function for experimental or therapeutic purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Vaccination","conceptCode":"C15346","definition":"Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis or treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4E3E2D2-0513-08F9-E053-731AD00AFB64","latestVersionIndicator":"Yes","beginDate":"2022-07-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-28","modifiedBy":"TSESU","dateModified":"2022-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"3260878","version":"1","preferredName":"Concomitant Medication","preferredDefinition":"Concomitant Medication per CDISC CM Definition","longName":"CM","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA1591D7-FC76-D679-E040-BB89AD43495D","latestVersionIndicator":"Yes","beginDate":"2011-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-09","modifiedBy":"DWARZEL","dateModified":"2017-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4E3E2D2-0514-08F9-E053-731AD00AFB64","latestVersionIndicator":"Yes","beginDate":"2022-07-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-28","modifiedBy":"TSESU","dateModified":"2022-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6343337","version":"1","preferredName":"CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator","preferredDefinition":"Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"NY","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F9FC413-3EDC-2FFB-E053-F662850AA144","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ONEDATA","dateModified":"2018-06-27","deletedIndicator":"No"},{"value":"Y","valueDescription":"Yes","ValueMeaning":{"publicId":"5676138","version":"1","preferredName":"Yes","longName":"5676138","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49204933-EF64-01C8-E053-F662850A7582","latestVersionIndicator":"Yes","beginDate":"2017-02-22","endDate":null,"createdBy":"ANDERSONR","dateCreated":"2017-02-22","modifiedBy":"MMADDINENI","dateModified":"2024-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F9FC413-3EF1-2FFB-E053-F662850AA144","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ONEDATA","dateModified":"2018-06-27","deletedIndicator":"No"},{"value":"NA","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73F48F3A-1DF1-2954-E053-F662850A5947","beginDate":"2018-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","deletedIndicator":"No"},{"value":"U","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73F48F3A-1DFD-2954-E053-F662850A5947","beginDate":"2018-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6343336","version":"1","preferredName":"CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator","preferredDefinition":"A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C66742:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDISC SDTM Yes No Unknown or Not Applicable Response Terminology","conceptCode":"C66742","definition":"Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F9FC413-3E96-2FFB-E053-F662850AA144","latestVersionIndicator":"Yes","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ONEDATA","dateModified":"2018-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6F9FC413-3EA7-2FFB-E053-F662850AA144","latestVersionIndicator":"Yes","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ZHWENDY","dateModified":"2023-12-12","changeDescription":"Elevated to Standard per governance approval by RA. 2021-6-9 ak  12/18/18 TT released/MC. 8-21-18 edit to PVs/CDISC revised submission values; tt.  Created as part of CDISC mapping task. 6.27.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"GAMMAG_CMOCCUR","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Is this a targeted concomitant medication (gamma globulin, immunosuppressive drug, or vaccination)?","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4E43AA0-53D4-1AFC-E053-731AD00AC12B","latestVersionIndicator":"Yes","beginDate":"2022-07-28","endDate":null,"createdBy":"TSESU","dateCreated":"2022-07-28","modifiedBy":"TSESU","dateModified":"2022-07-29","changeDescription":null,"administrativeNotes":"7/29/22 released CDE per Sung Tse for AMC cjl; 7/29/22_revised short name per M. Sheikh_smt","unresolvedIssues":null,"deletedIndicator":"No"}}